Merrimack Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Merrimack Pharmaceuticals Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Merrimack Pharmaceuticals Inc Strategy Report

  • Understand Merrimack Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Merrimack Pharmaceuticals Inc: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Merrimack Pharmaceuticals Clinical Trials

Determine Merrimack Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of Merrimack Pharmaceuticals Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 40+ results.
Deserunt mollit sunt Lorem GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Pfizer Inc
Phase II Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke (Arpeggio) GDCT0443981 SCP-776 Cardiovascular Acute Ischemic Stroke Phase II Ongoing, recruiting Silver Creek Pharmaceuticals Inc
Phase I Study of SCP-776 for Acute Ischemic Stroke GDCT0443977 SCP-776 Cardiovascular Acute Ischemic Stroke Phase I Completed Silver Creek Pharmaceuticals Inc
Phase I Study of SGF-1 in Healthy Subjects GDCT0305134 SGF-1 Cardiovascular; Central Nervous System; Genito Urinary System And Sex Hormones Acute Renal Failure (ARF) (Acute Kidney Injury); Myocardial Infarction; Traumatic Brain Injury Phase I Withdrawn Silver Creek Pharmaceuticals Inc
Clinical Trials

Feature

GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.

Benefit

The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).

Access:

  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.

Value

Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Gain a 360-degree view of Merrimack Pharmaceuticals Inc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer